Efficacy of oral single dose therapy with artemisinin-naphthoquine phosphate in uncomplicated falciparum malaria

Acta Tropica

Volumn 111, Issue 3, 2009, Pages 275-278

  Tun, Thein ^a   Tint, Hla Soe ^a   Lin, Khin ^a   Kyaw, Thar Tun ^b   Myint, Moe Kyaw ^a   Khaing, Win ^c   Tun, Zaw Win ^a  

^a Mandalay Division ^*  (Myanmar)

^b VBDC Divisional Office   (Myanmar)

^c University of Medicine   (Myanmar)

Author keywords

Antimalarial; Artemisinin; Combination; Falciparum malaria; Myanmar; Naphthoquine phosphate

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ PLUS NAPHTHOQUINE PHOSPHATE; UNCLASSIFIED DRUG;

DISEASE CONTROL; DISEASE TREATMENT; DRUG PRESCRIBING; MALARIA; PHOSPHATE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ARTICLE; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; OUTCOME ASSESSMENT; SINGLE DRUG DOSE; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; NAPHTHOQUINONES; PARASITEMIA; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME; YOUNG ADULT;

ASIA; EURASIA; MYANMAR; SOUTHEAST ASIA;

EID: 67650717309     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.05.007     Document Type: Article

References (19)

1. Adam I., Magzoub M., Osman M.E., Khalil I.F., Alifrangis M., and Elmardi K.A. A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan. Ann. Clin. Microbiol. Antimicrob. 5 (2006) 18
2. Alin M.H., Ashton M., Kihamia C.M., Mtey G.J.B., and Bjorkman A. Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria. Br. J. Clin. Pharmacol. 41 (1996) 587-592
3. Cravo P., Culleton R., Hunt P., Walliker D., and Mackinnon M.J. Antimalarial drugs clear resistant parasites from partially immune hosts. Antimicrob. Agents Chemother. 45 (2001) 2897-2901
4. Denis M.B., Tsuyuoka R., Yi P., Narann T.S., Seila S., Lim C., Incardona S., Lim P., Sem R., Socheat D., Christophel E.M., and Ringwald P. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop. Med. Int. Health 11 (2006) 1360-1366
5. Denis M.B., Tsuyuoka R., Lim P., Lindegardh N., Yi P., Top S.N., Socheat D., Fandeur T., Annerberg A., Christophel E.M., and Ringwald P. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop. Med. Int. Health 11 (2006) 1800-1807
6. ®) in Kajo Keji, southern Sudan. Ann. Trop. Med. Parasitol. 98 (2004) 635-637
7. Depoortere E., Guthmann J.P., Sipilanyambe N., Nkandu E., Fermon F., Balkan S., and Legros D. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop. Med. Int. Health 9 (2004) 62-67
8. Dorsey G., Kamya M.R., Ndeezi G., Babirye J.N., Phares C.R., Olson J.E., Katabira E.T., and Rosenthal P.J. Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. Am. J. Trop. Med. Hyg. 62 (2000) 686-692
9. Fogg C., Bajunirwe F., Piola P., Biraro S., Checchi F., Kiguli J., Namiiro P., Musabe J., Kyomugisha A., and Guthmann J.P. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am. J. Trop. Med. Hyg. 71 (2004) 525-530
10. Hutagalung R., Paiphun L., Ashley E.A., McGready R., Brockman A., Thwai K.L., Singhasivanon P., Jelinek T., White N.J., and Nosten F.H. A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Malar. J. 4 (2005) 46
11. Kachur S.P., Khatib R.A., Kaizer E., Fox S.S., Abdulla S.M., and Bloland P.B. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am. J. Trop. Med. Hyg. 71 (2004) 715-722
12. Li G.Q., Guo X.B., Fu L.C., Jian H.X., and Wang X.H. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg. 88 (1994) 5-6
13. Ogbonna A., and Uneke C.J. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000. Trans. R. Soc. Trop. Med. Hyg. 102 (2008) 621-627
14. Penali L.K., and Jansen F.H. Single-day, three-dose treatment with fixed dose combination artesunate/sulfamethoxypyrazine/pyrimethamine to cure Plasmodium falciparum malaria. Int. J. Infect. Dis. 12 (2008) 430-437
15. Vijaykadga S., Rojanawatsirivej C., Cholpol S., Phoungmanee D., Nakavej A., and Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop. Med. Int. Health 11 (2006) 211-219
16. Wang J., Cao W., Shan C., Zhang M., Li G., Ding D., Shi Y., and Wu B. Naphthoquine phosphate and its combination with artemisinine. Acta Trop. 89 (2004) 375-381
17. Wasunna B., Zurovac D., Goodman C.A., and Snow R.W. Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar. J. 7 (2008) 29
18. World Health Organization. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria (2003), WHO, Geneva
19. World Health Organization. Guidelines for the Treatment of Malaria (2006), WHO, Geneva